ADULT SOLID TUMOR
Clinical trials for ADULT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADULT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADULT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise in taming tough cancers
Disease control CompletedThis study tested a combination of two drugs, durvalumab (an immunotherapy) and tazemetostat (an epigenetic therapy), in 164 adults with advanced solid tumors like pancreatic, colorectal, and soft-tissue sarcoma. The goal was to see if the combo could shrink or stabilize tumors. …
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy shows promise for young cancer patients who relapsed
Disease control CompletedThis early-phase study tested a combination of three treatments—pembrolizumab, decitabine, and targeted radiation—in 22 children and young adults (ages 1 to 40) with relapsed or refractory solid tumors or lymphoma. The main goals were to see if the combination is safe and tolerab…
Matched conditions: ADULT SOLID TUMOR
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated May 12, 2026 13:40 UTC